메뉴 건너뛰기




Volumn 103, Issue 3, 2008, Pages 802-803

Blood cultures of 19 Crohn's disease patients

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; INFLIXIMAB; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN;

EID: 40949153068     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01612_6.x     Document Type: Letter
Times cited : (9)

References (3)
  • 1
    • 4544279029 scopus 로고    scopus 로고
    • Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease
    • Naser SA, Ghobrial G, Romero C, et al. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004 364 : 1039 44.
    • (2004) Lancet , vol.364 , pp. 1039-44
    • Naser, S.A.1    Ghobrial, G.2    Romero, C.3
  • 2
    • 34250030068 scopus 로고    scopus 로고
    • Two-year combination antibiotic therapy with clarithromycin, riofabutin, and clafazimine for Crohn's disease
    • Selby W, Pavill P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, riofabutin, and clafazimine for Crohn's disease. Gastroenterology 2007 132 : 2313 9.
    • (2007) Gastroenterology , vol.132 , pp. 2313-9
    • Selby, W.1    Pavill, P.2    Crotty, B.3
  • 3
    • 0037018761 scopus 로고    scopus 로고
    • Maintenance infliximab for Crohn's disease: The accent/randomised trial
    • Hanauer SB, Feaqgan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: The accent/randomised trial. Lancet 2002 359 : 1541 9.
    • (2002) Lancet , vol.359 , pp. 1541-9
    • Hanauer, S.B.1    Feaqgan, B.G.2    Lichtenstein, G.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.